using semaglutide for weight loss 3 mg tablet Semaglutide Injections for Weight Loss

Tirzepatide (Mounjaro/Zepbound) activates GLP-1 and GIP receptors

Among CagriSema-treated participants, 73.5% achieved HbA1c of 6.5% or below compared to 15.9% with placebo, demonstrating remarkable dual efficacy for both weight and glycemic endpoints

Silver Spring, Md) 2023;31(3):703715

Gastrointestinal Effects Nausea is the most commonly reported side effect, and women experience it at higher rates (31% vs 24% in men)

Repeated exposure to stomach acid can erode tooth enamel and increase sensitivity, she explained

Competition between major pharmaceutical companies is accelerating innovation in oral GLP-1 therapies, especially in small-molecule drug development